The goal of this research study is to compare the impact of video directly observed therapy on inhaler technique accuracy with participants receiving video directly observed therapy vs. participants receiving standard asthma care. Participants will be randomized between the two groups. We will follow up and compare the two groups to see if they have improved asthma control as measured by symptom-free days (SFD), higher inhaler technique at 3-month follow up, higher checklist scores on a standardized inhaler technique checklist, higher proportion of days covered (PDC) of their inhaled asthma controller medication, and have fewer acute care visits for asthma.
Who can participate
Age range6 Years – 11 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥ 6 and ≤ 11 years old
✓. Physician diagnosed persistent asthma (any severity) and verified by review of electronic medical record
✓. New patient with a new prescription for inhaled preventive asthma medication referred to an asthma subspecialty clinic at Arkansas Children's OR established patient in the asthma, allergy or pulmonary subspecialty clinic with a new prescription for inhaled preventive asthma medication.
✓. Regular access to Wi-Fi
Exclusion criteria
✕. Significant underlying respiratory disease other than asthma such as cystic fibrosis
✕. Significant co-morbid conditions, such as moderate to severe developmental delay that could interfere with the ability to communicate via interactive video
✕. Current smoker
✕. Caregiver/patient does not have access to a smartphone compatible with the Emocha® smartphone application
✕
What they're measuring
1
Inhaler technique
Timeframe: 3 months
2
Symptom-free days
Timeframe: 3 months
3
Healthcare utilization
Timeframe: 3 months
4
Medication Adherence
Timeframe: 3 months
Trial details
NCT IDNCT05120323
SponsorArkansas Children's Hospital Research Institute